Last updated on March 2016

A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke


Brief description of study

A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke

Detailed Study Description

This study is being conducted to determine the safety and efficacy of stem cells administered by injection into the brain around the area of the stroke.

Clinical Study Identifier: TX143018

Contact Investigators or Research Sites near you

Start Over

Tara McTigue

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa, FL USA
  Connect »